However, other studies paint a more complicated picture of the impact of TLR agonists on HIV infection—Brichacek et al. found that TLR9 agonists inhibited HIV replication in ex vivo cultures of lymphoid tissue, while TLR5 agonists enhanced infection [124]. This evidence concerns the gene TLR9 and infection.